PSNL Personalis, Inc.

NASDAQ

$16.46

Personalis, Inc. (PSNL) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.26 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +22.5% since its last earnings release on August 4, 2026.

Personalis Missed Consensus Estimates

Tuesday, August 4, 2026 · 4:01 PM ET

3rd Quarter, Sep 2026

Monday · 4:00 PM ET

Earnings Whisper

-

vs ($0.26)

Rev est $22.87M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $16.28

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Personalis, Inc.

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency, and quality.

Sector

Healthcare

Industry

Medical Labs & Research

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.